Last reviewed · How we verify
NCT03581201
The Relationship of the Intestinal Microbiome and the Menstrual Cycle
trial testing Laboratory measurements in Sex Hormones in 20 participants. Status unknown.
13 June 2020
Quick facts
| Lead sponsor | Medical University of Vienna |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 18 July 2018 |
| Primary completion | 13 June 2020 |
| Estimated completion | 1 July 2020 |
| Sites | 1 location across Austria |
Drugs / interventions tested
- Laboratory measurements
- Stool samples — full drug profile →
- Bioimpedance analysis — full drug profile →
Conditions studied
- Sex Hormones — all drugs for Sex Hormones →
- Microbial Colonization — all drugs for Microbial Colonization →
Sponsor
Medical University of Vienna
Who can join
Adults 18 to 40, female only, with Sex Hormones or Microbial Colonization. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In the present study the dynamic changes of the intestinal microbiome are observed over a 4-week period in the different stages of the menstrual cycle in women at childbearing age. The focus is on how the dynamic changes of sex hormones during a menstrual cycle of women at childbearing age (with or without contraception) are related to microbiological colonization of the gut. In Addition the Expression of the β-glucuronidase by the bacteria will be investigated.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03581201
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Laboratory measurements
Trials testing the same drug.
- NCT04753307 — Perioperative Inflammatory Response Assessment in High-risk Patients Undergoing Noncardiac Surgery · unknown
- NCT03106688 — Neuromolecular Risk Factors for Obesity (PROSPECT) · NA · unknown
Other Medical University of Vienna trials
Trials by the same sponsor.
- NCT07473401 — Retinal Oxygen Metabolism in Children With Myopia · not yet recruiting
- NCT07511400 — The Role of NaV1.8 in Human Pain Models · EARLY_PHASE1 · not yet recruiting
- NCT07516990 — Intramuscular Injection of Mashed Parathyroid Tissue Into a Forearm During Thyroid Surgery to Prevent Permanent Postoper · NA · recruiting
- NCT07496437 — Is Cross-linked Hyaluronic Acid a Biologic Alternative for Alveolar Ridge Preservation? · NA · not yet recruiting
- NCT07290712 — Post-Intensive Care Syndrome - Multicentre Prospective Registry Database of the DACH Region · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03581201 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University of Vienna
- Last refreshed: 3 September 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03581201.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing